Filing Details

Accession Number:
0001181431-10-016927
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-17 13:00:00
Reporting Period:
2010-03-15
Filing Date:
2010-03-17
Accepted Time:
2010-03-17 16:41:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1454983 S Richard Levy Experimental Station
Route 141 And Henry Clay Rd
Wilmington DE 19880
Evp, Chief Drug Dev&Medical Of No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-15 20,000 $4.19 20,000 No 4 M Direct
Common Stock Disposition 2010-03-15 20,000 $12.94 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Options Disposition 2010-03-15 20,000 $0.00 20,000 $4.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2013-08-17 No 4 M Direct
Footnotes
  1. Beginning August 18, 2003, options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remainder vesting monthly over three years.